J&M Shuler Report issue

For profit Phase 3
Founded: Athens GA United States (2011)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2018
NCT03583151
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

J&M Shuler